- T4+T3 Combination Therapy: An Unsolved Problem of Increasing Magnitude and Complexity
-
Wiersinga WM
- KMID: 2521942
- Endocrinol Metab.
- 2021 Oct;36(5):938-951.
- doi: 10.3803/EnM.2021.501
Thyroxine (T4)+triiodothyronine (T3) combination therapy can be considered in case of persistent symptoms despite normal serum thyroid stimulating hormone in levothyroxine (LT4)-treated hypothyroid patients. Combination therapy has gained popularity in... -
- CITED
-
- Close
- SHARE
-
- Close
